APA (7th ed.) Citation

Park, S., Chung, M. J., Park, J. Y., Chung, J. B., Bang, S., Park, S. W., & Song, S. Y. (2013). Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response. Gut and liver, 7(5), 611-615. https://doi.org/10.5009/gnl.2013.7.5.611

Chicago Style (17th ed.) Citation

Park, Semi, Moon Jae Chung, Jeong Youp Park, Jae Bock Chung, Seungmin Bang, Seung Woo Park, and Si Young Song. "Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response." Gut and Liver 7, no. 5 (2013): 611-615. https://doi.org/10.5009/gnl.2013.7.5.611.

MLA (9th ed.) Citation

Park, Semi, et al. "Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response." Gut and Liver, vol. 7, no. 5, 2013, pp. 611-615, https://doi.org/10.5009/gnl.2013.7.5.611.